A41. COPD: EPIDEMIOLOGY

Exacerbation Rate in COPD Patients - Two Years Follow-Up Cohort

Pub Date : 2019-05-01 DOI: 10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a1602 O. Nascimento, Cláudia S Silva, A. A. A. Neto, M. Gazzotti, J. Jardim

Clinically Meaningful Reduction in Hyperinflation with Zephyr Endobronchial Valves (Zephyr Valve) Associated with Sustained Longitudinal Improvements in Lung Function, Exercise Tolerance, QoL and Dyspnea

Pub Date : 2019-05-01 DOI: 10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a7308 F. Sciurba, J. Bon, R. Sue, Shawn Wright, H. Rivas-Perez, T. Wiese, U. Gauhar, B. Morrissey, K. Yoneda, H. G. Oliveira, A. Macedo, M. Wahidi, P. Cardoso, F. Oliveira, N. Pastis, C. Strange, M. Dransfield, S. Bhatt, S. Kemp, J. Garner, S. Radhakrishnan, N. Shargill, N. Marchetti, G. Criner, N. T. Hacken, D. Slebos

Forced Vital Capacity (FVC) May Be an Independent Marker for Assessing Clinical Outcomes in Chronic Obstructive Pulmonary Disease (COPD)

Pub Date : 2019-05-01 DOI: 10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a1599 W. Seo, T. An